CYNTHIA CRUZ: Open Payments
NPI 1154820116 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 30 payments from 17 companies in 2025. Trend: 2023 $847 · 2024 $1,167 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $172 |
| Corcept Therapeutics | 2 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Lilly USA, LLC | 2 | $29 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: FREESTYLE LIBRE 3, Korlym, XIFAXAN, TZIELD, Kerendia, MOUNJARO, NEFFY, SPRAVATO.
Industry payments across TX — which companies pay providers there.
